XML 59 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Note 14 - Contingently Redeemable Noncontrolling Interests (Details Textual)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
Jun. 30, 2021
USD ($)
$ / shares
Temporary Equity, Accretion to Redemption Value   $ 62
Series A-2 Preferred Shares [Member] | Research Collaboration and License Agreement with Eli Lilly [Member] | SEED Therapeutics Inc. [Member]    
Temporary Equity, Stock Issued During Period, Value, New Issues   $ 0
Share Price (in dollars per share) | $ / shares $ 0.50 $ 0.50
Convertible Instrument, Conversion Price (in dollars per share) | $ / shares $ 2.5125 $ 2.5125
Temporary Equity, Accretion to Redemption Value $ 62 $ 62